Indiana Biosciences Research Institute
1345 W. 16th Street
About Indiana Biosciences Research Institute
The Indiana Biosciences Research Institute (IBRI) is an independent, nonprofit discovery science and applied research institute focused on the discovery and development of innovative solutions to improve health, initially targeting diabetes, metabolic disease and poor nutrition. Inspired by the State of Indiana and Indiana’s leading life sciences companies, research universities and philanthropic community, the IBRI is building a world-class organization of researchers, innovators, and entrepreneurs that will catalyze scientific discovery and its application, resulting in improved health outcomes for patients. Researchers at the IBRI work in collaboration with industry and academic partners to advance life sciences research to accelerate the development of innovation.
12 articles with Indiana Biosciences Research Institute
Point-of-care testing is a critical tool in the battle against COVID-19, and researchers in Indiana are working around the clock to deliver rapid tests with high specificity.
Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Ins...
11/21/2019A peculiarity of autoimmune diseases is that they have many genes in common, but they develop differently.
This partnership will leverage Virtusa’s vLife open innovation platform to enable organizations to work in a connected ecosystem that allows them to access, validate, and adopt other firms’ technologies and enhance the entire research and development process.
There have been a number of leadership changes in the life sciences industries over the past week. BioSpace compiled a roundup of the changing landscape of the c-suite and boards of directors across the industry.
The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Stephanie Grinage as vice president for Advancement.
Indiana Biosciences Research Institute names executive director of engagement, communications and external affairs
The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Mark E. Craft as executive director of engagement, communications and external affairs.
Pharma and biotech companies across the globe continued to expand and reshape their leadership teams with new hires this past week. BioSpace collected several announced leadership appointments, which includes new chief executive officers, new members to boards of directors and more.
The Indiana Biosciences Research Institute (IBRI) announces former Eli Lilly and Company chairman, president and CEO John C. Lechleiter, Ph.D., has joined its board of directors. Dr. Lechleiter retired from Lilly in 2016 and served as chairman of the board of directors from January 2009 to May 2017. He joined Lilly in 1979 as a senior organic chemist, working his way from the lab to global leadership.
McGill brings vast experience in collaboration, partnership, research operations and ventures to the IBRI.
Indiana Biosciences Names Leading Researcher And Innovator Rainer Fischer, Ph.D., As Chief Scientific And Innovation Officer